CN Patent
CN1919184A — 吗替麦考酚酯分散片及其制备方法
Assigned to Individual · Expires 2007-02-28 · 19y expired
What this patent protects
本发明公开了一种吗替麦考酚酯分散片及其制备方法。该吗替麦考酚酯分散片含有以下重量份的原料:吗替麦考酚酯125-500份、填充剂30-120份、崩解剂25-150份、甜味剂6-24份、润滑剂0.5-5份。该吗替麦考酚酯分散片具有崩解时间短、分散状态佳、药物溶出迅速、吸收快、生物利用度高的优点,尤其适合老人及吞服困难的患者。
USPTO Abstract
本发明公开了一种吗替麦考酚酯分散片及其制备方法。该吗替麦考酚酯分散片含有以下重量份的原料:吗替麦考酚酯125-500份、填充剂30-120份、崩解剂25-150份、甜味剂6-24份、润滑剂0.5-5份。该吗替麦考酚酯分散片具有崩解时间短、分散状态佳、药物溶出迅速、吸收快、生物利用度高的优点,尤其适合老人及吞服困难的患者。
Drugs covered by this patent
- Cellcept (MYCOPHENOLATE MOFETIL) · Roche Palo
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.